免疫刺激剂
佐剂
免疫系统
免疫增强剂
辛伐他汀
乳状液
黄芪
甘露聚糖
化学
多糖
免疫学
药理学
生物
医学
生物化学
替代医学
中医药
病理
作者
Shuwen Xu,Zhi‐Yong Wu,Gaofeng Cai,Yue Zhang,Peng Song,Lina Jiao,Zhenguang Liu,Yang Yang,Deyun Wang
出处
期刊:Vaccine
[Elsevier]
日期:2023-03-01
卷期号:41 (10): 1684-1693
被引量:2
标识
DOI:10.1016/j.vaccine.2023.01.069
摘要
Oil-in-water emulsion-based adjuvants have demonstrated acceptable safety in many disease indications, while their adjuvant activities for vaccines still need to be improved. Recently, the strategy of combining adjuvants with multiple types of immunostimulants has been shown to enhance immune responses. In this study, astragalus polysaccharides were combined with simvastatin as an immunostimulant to construct a compound O/W emulsion adjuvant. The formulations were optimized according to the OVA-specific antibody responses induced in mice. For this reason, high (5 mg/mL), medium (2.5 mg/mL), and low (1.25 mg/mL) concentrations of astragalus polysaccharides and high (10 mg/mL), medium (1 mg/mL), and low (0.1 mg/mL) concentrations of simvastatin were selected. The final optimal formulation of the immunostimulant was a high concentration of astragalus polysaccharides combined with a medium concentration of simvastatin. The optimal compound O/W emulsion adjuvant could induce effective humoral and cellular immune responses that were stronger and more stable than those induced by aluminum adjuvant and Freund's adjuvant. The OVA/HAPS-MSim-OE induced dramatically strong and persistent IgG expressions and Th1-polarized immune responses. What's more, the highest CD4+/CD8+lymphocyte ratios were observed in OVA/HAPS-MSim-OE group. In addition, compound O/W emulsion adjuvant groups significantly promoted the secretion of IFN-γ and IL-6, which also indicated that the compound O/W emulsion adjuvants could induce both enhanced Th1 and Th2-mediated immune responses but prefer the Th1-mediated ones. This study would contribute to an interesting and promising direction in the development of emulsion-based adjuvants.
科研通智能强力驱动
Strongly Powered by AbleSci AI